when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LEADING · news · pharmadog

← back to LEADING

News mentioning LEADING

653 stories

Aug 13, 26PTC takes a chance on Sangamo’s Fabry disease gene therapybiopharma dive

Aug 13, 26Medtronic veteran Bill Shields crosses over to become CEO at valve disease startupfiercebiotech

Aug 12, 26Oma's Pride Voluntarily Recalls One Lot of Woof Complete Canine Chicken Recipe (6 Lb Bag) Because of Possible Salmonella Health Riskfda recalls

Aug 12, 26Kettle Cuisine Recalls Marketside Tomato Bisque Soup Kit – Sold Exclusively at Walmart Stores Because of Possible Health Riskfda recalls

Aug 12, 26Whole Foods Market Announces a Recall of Select Salsas, Guacamole, Pico de Gallo, and Prepared Foods Products Because of Possible Health Riskfda recalls

Aug 12, 26Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pillfiercebiotech

Aug 12, 26Post-Hoc: Rewatch the Boston edition of our China Biotech Debateendpoints

Aug 11, 26Stopping statins in people over 75 at low risk for heart disease didn’t increase deathsstat

Aug 11, 26STAT+: Trump is counting on the health care industry to remake vaccines. It’s pushing back insteadstat

Aug 11, 26How we know that splitting up the MMR vaccine could be dangerousstat

Aug 11, 26Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugsfiercebiotech

Aug 11, 26Scholar Rock rejigs approval filing after FDA flags violations at Novo plantbiospace

Aug 11, 26Ex-Legend chief Ying Huang becomes CEO of K2, eyes $250M Series Aendpoints

Aug 11, 26Vaderis hauls in $152M to test an AKT-targeting drugbiopharma dive

Aug 11, 26After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’fiercebiotech

Aug 11, 26STAT+: Nurses seek a seat at the table as they fight expanding clinical AIstat

Aug 10, 26Regeneron backs $75M series A for antibody upstart Infinimmunefiercebiotech

Aug 10, 26FDA to require notice of additives in food supply for the first timestat

Aug 10, 26Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the massesbiopharma dive

Aug 10, 26STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal studystat

Aug 10, 26STAT+: The promise of radiopharmaceuticals smacks into safety concernsstat

Aug 10, 26FDA issues alert in wake of BD recall of faulty needle setsfiercebiotech

Aug 10, 26Sobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 pushfiercebiotech

Aug 9, 26Novo Nordisk and Amazon sign AI drug discovery pact, launch London innovation hubfiercebiotech

Aug 7, 26Opinion: Fauci doesn’t have the answers on Covid’s origins. China doesstat

Aug 7, 26Ledende medarbejder transaktionglobenewswire health

Aug 7, 26Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attackstat

Aug 6, 26Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800Mbiopharma dive

Aug 6, 26Chutes & Ladders—BioNTech brings in Sobi CEOfiercebiotech

Aug 6, 26STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug developmentstat

← prevpage 12 of 22next →